N-glycoproteomics reveals distinct glycosylation alterations in NGLY1 deficient patient-derived dermal fibroblasts

Congenital disorders of glycosylation are genetic disorders which occur due to defects in protein and lipid glycosylation pathways. A deficiency of N-glycanase 1, encoded by the NGLY1 gene, results in a congenital disorder of deglycosylation. The NGLY1 enzyme is mainly involved in cleaving N-glycans from misfolded, retro-translocated glycoproteins in the cytosol from the endoplasmic reticulum prior to their proteasomal degradation or activation. Despite the essential role of NGLY1 in deglycosylation pathways, the exact consequences of NGLY1 deficiency on global cellular protein glycosylation have not yet been investigated. We undertook a multiplexed tandem mass tags (TMT)-labeling based quantitative glycoproteomics and proteomics analysis of fibroblasts from NGLY1 deficient individuals carrying different biallelic pathogenic variants in NGLY1.